Učitavanje...

Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia

Current therapies for acute myeloid leukemia are associated with high failure and relapse rates. Adoptive immunotherapies, which have shown promise in the treatment of hematologic malignancies, have the potential to target acute myeloid leukemia through pathways that are distinct and complementary t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Haematologica
Glavni autori: O’Hear, Carol, Heiber, Joshua F., Schubert, Ingo, Fey, Georg, Geiger, Terrence L.
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349272/
https://ncbi.nlm.nih.gov/pubmed/25480499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.112748
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!